FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:274-275 July 28, 1994 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Lipton, S. A. PubMed Citation

To the Editor: Lipton and Rosenberg (March 3 issue)¹ explored the role of excitatory amino acids as a final common pathway for neurologic disorders. Their findings rekindle the question of the effect of ingestion of neurotoxic amino acids on neurologic disorders associated with endogenous neurotoxic amino acids.

The question of the role of exogenous neurotoxic amino acids was first raised by Olney in 1969². The food industry has since removed monosodium glutamate from baby food, and consumers have continued to submit reports of adverse reactions to the additive to the Food and Drug Administration's Adverse Reactions Monitoring System.

The . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.